Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Par Pharmaceutical Companies Inc.

http://www.parpharm.com

Latest From Par Pharmaceutical Companies Inc.

Who’s Hired? IGBA Names IPA’s Jain As Chair

The International Generic and Biosimilar Medicines Association has named the IPA’s Sudarshan Jain as its new chair. While Celltrion’s chairman has stepped down, Coherus has added two members to its board of directors and Synthon has appointed a new CEO.

Appointments International

Pfizer Faces 15-Year Wait On US Adrenalin Generic

Pfizer’s efforts to circumvent two US patents shielding Par’s Adrenalin (epinephrine) have again ended in failure, following a ruling by the US Court of Appeals for the Federal Circuit.

Intellectual Property Generic Drugs

Finance Watch: Two New VC Funds Raise $755m To Fund Innovation

Private Company Edition: Also, Medicxi’s new €200m fund will be reinvested in a portfolio of six life science companies and Silverback more than doubled its 2020 money with an $85m series C round.

Financing StartUps and SMEs

Endo’s Par Competes With Amneal On Sucralfate

Endo’s Par has partnered with Allergan to launch an authorized generic of Carafate sucralfate oral suspension in the US, competing directly with the first generic version recently launched by Amneal.

Launches Generic Drugs
See All

Company Information

  • Other Names / Subsidiaries
    • Anchen Pharmaceuticals, Inc.
    • Edict Pharmaceuticals Private Limited
    • JHP Pharmaceuticals, LLC
    • Strativa Pharmaceuticals
    • TPG Capital LP
UsernamePublicRestriction

Register